High-throughput identification of refolding conditions for LXRβ without a functional assay

Protein Expression and Purification

Volumn 47, Issue 2, 2006, Pages 355-366

  Lin, Laura ^a   Seehra, Jasbir ^a   Stahl, Mark L ^a  

^a PFIZER INC   (United States)

Author keywords

Inclusion bodies; Liver X receptor ; Protein folding; Refolding screen

Indexed keywords

CELL RECEPTOR; COLLAGENASE; COLLAGENASE 3; DNA BINDING PROTEIN; INTERLEUKIN 13; LIVER X RECEPTOR; MMP13 PROTEIN, HUMAN; MMP13 PROTEIN, RAT; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; CHEMISTRY; ECONOMICS; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; PROTEIN FOLDING; RAT;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLLAGENASES; DNA-BINDING PROTEINS; HUMANS; INTERLEUKIN-13; MATRIX METALLOPROTEINASE 13; PROTEIN FOLDING; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECOMBINANT PROTEINS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MAMMALIA;

EID: 33646580434     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2005.11.010     Document Type: Article

References (36)

1. Lilie H., Schwarz E., and Rudolph R. Advances in refolding of proteins produced in E. coli. Curr. Opin. Biotech. 9 (1998) 497-501
2. Misawa S., and Kumagai I. Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies. Biopolymers (Peptide Science) 51 (1999) 297-307
3. Rudolph R., and Lilie H. In vitro folding of inclusion body proteins. FASEB J. 10 (1996) 49-56
4. De Bernardez Clark E. Refolding of recombinant proteins. Curr. Opin. Biotech. 9 (1998) 157-163
5. Chaudhuri J.B. Refolding of recombinant proteins: process strategies and novel approaches. Ann. N. Y. Acad. Sci. 721 (1994) 374-385
6. Li M., Su Z.-G., and Janson J.-C. In vitro protein refolding by chromatographic procedures. Protein Expr. Purif. 33 (2004) 1-10
7. Middelberg A. Preparative protein refolding. Trends Biotechnol. 20 (2002) 437-443
8. Chen G., and Gouaux E. Overexpression of a Glutamate Receptor (GluR2) ligand binding domain in Escherichia coli: application of a novel protein folding screen. Proc. Natl. Acad. Sci. USA 94 (1997) 13431-13436
9. Armstrong N., De Lencastre A., and Gouaux E. A new protein folding screen: application to the ligand binding domains of a glutamate and kainate receptor and to lysozyme and carbonic anhydrase. Protein Sci. 8 (1999) 1475-1483
10. Tobbell D.A., Middleton B.J., Raines S., Needham M.R.C., Taylor I.W.F., Beveridge J.Y., and Abbott W.M. Identification of in vitro folding conditions for procathepsin S and cathepsin S using fractional factorial screens. Protein Expr. Purif. 24 (2002) 242-254
11. Heiring C., and Muller Y.A. Folding screening assayed by proteolysis: application to various cystine deletion mutants of vascular endothelial growth factor. Protein Sci. 14 (2001) 183-188
12. Scheich C., Niesen F.H., Seckler R., and Bussow K. An automated in vitro protein folding screen applied to a human dynactin subunit. Protein Sci. 13 (2004) 370-380
13. Scheich C., Leitner D., Sievert V., Leidert M., Schlegel B., Simon B., Letunic I., Bussow K., and Diehl A. Fast identification of folded human protein domains expressed in E. coli suitable for structural analysis. BMC Struct. Biol. 4 (2004) 4
14. Eisenmesser E.Z., Horita D.A., Altieri A.S., and Byrd R.A. Solution structure of interleukin-13 and insights into receptor engagement. J. Mol. Biol. 310 (2001) 231-241
15. Moy F.J., Diblasio E., Wilhelm J., and Powers R. Solution structure of human IL-13 and implication for receptor binding. J. Mol. Biol. 310 (2001) 219-230
16. Moy F.J., Pisano M.R., Chanda P.K., Urbano C., Killar L.M., Sung M.L., and Powers R. Assignments, secondary structure and dynamics of the inhibitor-free catalytic fragment of human fibroblast collagenase. J. Biomol. NMR 10 (1997) 9-19
17. Lovejoy B., Welch A.R., Carr S., Luong C., Broka C., Hendricks R.T., Campbell J.A., Walker K.A.M., Martin R., Van Wart H., and Browner M.F. Crystal structures of MMP-1 and -13 reveal the structural basis for seletivity of collagenase inhibitors. Nat. Struct. Biol. 6 (1999) 217-221
18. Janowski B.A., Grogan M.J., Jones S.A., Wisely G.B., Kliewer S.A., Corey E.J., and Mangelsdorf D.J. Structural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβ. Proc. Natl. Acad. Sci. USA 96 (1999) 266-271
19. Schultz J.R., Tu H., Luk A., Repa J.J., Medina J.C., Li L., Schwendner S., Shelley W., Thoolen M., Mangelsdorf D.J., Lustig K.D., and Shan B. Role of LXRs in constrol of lipogenesis. Genes Dev. 14 (2000) 2831-2838
20. Williams S., Bledsoe R.K., Collins J.L., Boggs S., Lambert M.H., Miller A.B., Moore J., McKee D.D., Moore L., Nichols J., Parks D., Watson M., Wisely B., and Willson T.M. X-ray crystal structure of the liver X receptor b ligand binding domain: regulation by a histindine-tryptophan switch. J. Biol. Chem. 278 (2003) 27138-27143
21. Farnegardh M., Bonn T., Sun S., Ljunggren J., Ahola H., Wilhelmsson A., Gustafsson J.-A., and Carlquist M. The Three-dimensional structure of the liver X receptor {β} reveals a flexible ligand-binding pocket that can accommodate fundamentally different ligands. J. Biol. Chem. 278 (2003) 38821-38828
22. Moy F.J., Chanda P.K., Chen J.M., Cosmi S., Edris W., Levin J.I., and Powers R. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor. J. Mol. Biol. 302 (2000) 671-689
23. Williams S.P., and Sigler P.B. Atomic structure of progesterone complexed with its receptor. Nature 393 (1998) 392-396
24. Matias P.M., Donner P., Coelho R., Thomaz M., Peixoto C., Macedo S., Otto N., Joschko S., Scholz P., Wegg A., Basler S., Schafer M., Egner U., and Carrondo M.a. Structural evidence for ligand specificity in the binding domain of the human androgen receptor: Implications for pathogenic gene mutations. J. Biol. Chem. 275 (2000) 26164-26171
25. Woody R.W. Circular dichroism of peptides. In: Neurath H. (Ed). The peptides (1988), Academic Press, New York 15-114
26. Privalov P.L. Stability of proteins: small globular proteins. Adv. Protein Chem. 33 (1979) 167-241
27. Anfinsen C.B., and Haber E. Studies on the reduction and re-formation of protein disulfide bonds. J. Biol. Chem. 236 (1961) 1361-1363
28. Anfinsen C.B. Principle that govern the folding of protein chains. Science 181 (1973) 223-230
29. Hart R.A., Giltinan D.M., Lester P.M., Reifsnyder D.H., Ogez J.R., and Builder S.E. Effect of environment on insulin-like growth factor I refolding selectivity. Biotechnol. Appl. Biochem. 20 (1994) 217-232
30. Egea P.F., Mitschler A., Rochel N., Ruff M., Chambon P., and Moras D. Crystal structure of the human RXRa ligand-binding domain bound to its natural ligand: 9-cis retinoic acid. EMBO J. 19 (2000) 2592-2601
31. Tanenbaum D.M., Wang Y., Williams S.P., and Sigler P.B. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc. Natl. Acad. Sci. USA 95 (1998) 5998-6003
32. McLaughlin S.H., and Jackson S.E. Folding and stability of the ligand-binding domain of the glucocorticoid receptor. Protein Sci. 11 (2002) 1926-1936
33. Cheung J., and Smith D.F. Molecular chaperone interactions with steroid receptors: An update. Mol. Endocrinol. 14 (2000) 939-946
34. Oneda H., and Inouye K. Refolding and recovery of recombinant human Matrix Metalloproteinase 7 (Matrilysin) from inclusion bodies Expressed by Escherichia coli. J. Biochem. 126 (1999) 905-911
35. Raschdorf F., Dahinden R., Maerki W., Richter W.J., and Merryweather J.P. Location of disulphide bonds in human insulin-like growth factors systhesized by recombinant DNA technology. Biomed. Environ. Mass Spectrom. 16 (1988) 3-8
36. Smith M.C., Cook J.A., Furman T.C., and Occolowitz J.L. Structure and activity dependence of recombinant human insulin-like growth factor 2 on disulfide bond pairing. J. Biol. Chem. 264 (1989) 9314-9321